Latest News for: bionic

Edit

ROSEN, A LEADING LAW FIRM, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before

The Eagle-Tribune 10 Oct 2026
NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- ... .
Edit

Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - ...

Morgan Citizen 10 Oct 2026
("Beta Bionics" or the "Company") (NasdaqGM.
Edit

Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

PR Newswire 10 Oct 2026
Foti, Jr., notifies investors in Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NasdaqGM ... Beta Bionics investors should contact KSF Managing Partner Lewis Kahn toll-free at ... Beta Bionics, Inc.
Edit

Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000

Enid News & Eagle 09 Oct 2026
... lawsuit against Beta Bionics, Inc. (“Beta Bionics” .
Edit

BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit

Morgan Citizen 09 Oct 2026
NEW YORK, Oct. 8, 2026 /PRNewswire/ -- ... .
Edit

BBNX Securities Alert: Lose Money on Your Beta Bionics Investment? BFA Law Notifies Investors of ...

Nasdaq Globe Newswire 09 Oct 2026
Lose Money on Your Beta Bionics Investment? BFA Law Notifies Investors of the Filed Securities Class Action over Medical Device Safety Issues ... .
Edit

Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the ...

Nasdaq Globe Newswire 09 Oct 2026
Kaplan Fox announces a securities class action against Beta Bionics (NASDAQ. BBNX) for investors from July 30, 2025 to Feb. 24, 2026 ... .
Edit

Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before

Hastings Tribune 09 Oct 2026
NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ. BBNX) on behalf of investors that purchased or ... .
Edit

Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead ...

Nasdaq Globe Newswire 09 Oct 2026
... in a securities class action lawsuit against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NasdaqGM.
Edit

GreyOrange Accelerates Physical AI Strategy With Acquisition of Site Bionics (Grey Orange Pte Ltd)

Public Technologies 09 Oct 2026
8, 2026 - GreyOrange, the global leader in AI-powered multi-agent warehouse orchestration and store inventory software, today announced it has acquired Site Bionics, the developer of an AI-powered digital twin platform ... About Site Bionics.
Edit

GreyOrange Accelerates Physical AI Strategy With Acquisition of Site Bionics

Nasdaq Globe Newswire 08 Oct 2026
GreyOrange adds AI-powered digital twin platform developed by Site Bionics to gStore inventory management ... .
Edit

Kirby McInerney LLP Alerts Investors Who Acquired Beta Bionics, Inc. BBNX Securities Between July 30, ...

Business Wire 08 Oct 2026
NEW YORK--(BUSINESS WIRE)---- $BBNX #ClassActionLawsuit--Kirby McInerney LLP reminds Beta Bionics, Inc.
Edit

BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, ...

The Daily Record - Dunn 08 Oct 2026
LOS ANGELES, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP, a national shareholder rights litigation ....
Edit

Beta Bionics (BBNX) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before November 3, 2026 Lead Plaintiff Deadline

PR Newswire 08 Oct 2026
8, 2026 /PRNewswire/ -- Beta Bionics, Inc ... The lawsuit follows a series of surprise revelations about the FDA's concerns over company's automated insulin delivery system ("iLet"), each of which sent the price of Beta Bionics shares sharply lower.
Edit

BBNX Deadline Alert: SueWallSt Reminds Beta Bionics, Inc. (BBNX) Investors of Securities Class Action Deadline on November 3, 2026

PR Newswire 08 Oct 2026
A securities class action alleges Beta Bionics assured shareholders that an FDA Form 483 was a "very benign" reporting technicality, and investor confidence held for months until the agency's Warning Letter became public and BBNX shares declined.

Article Search

tools
×
×
×
×